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Abstract
Background
Interventions incorporating constructs from behavioral economics and psychology have the
potential to enhance HIV ‘treatment as prevention’ (TasP) strategies. To test this hypothe-
sis, we evaluated an intervention to improve antiretroviral therapy (ART) adherence based
on the concepts of social norms and priming.
Methods
We used tools from marketing research and patient-centered design to develop a combina-
tion intervention that included visual feedback about clinic-level retention in care, a self-rele-
vant prime, and useful take-home items with the priming image. The intervention was
implemented at two HIV primary clinics in Shinyanga, Tanzania in 2-week intervals for six
months. We conducted a quasi-experimental pilot study with a random sample of exposed
and unexposed adult patients living with HIV infection (PLHIV) to compare retention and the
proportion of patients with medication possession ratio (MPR)95% after six months. Inter-
vention acceptability was determined with a convenience sample of 405 PLHIV at baseline
(n = 189) and endline (n = 216).
Results
Medical records were reviewed for 438 PLHIV (320 intervention, 118 standard of care). In
adjusted analyses, PLHIV exposed to the intervention were significantly more likely to be in
care after 6 months (87% vs. 79%, adjusted odds ratio (ORa) = 1.73, 95% CI: 1.08, 2.78,
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p<0.05) and were more likely to achieve MPR95% (70% vs. 59%, OR = 1.51, 95% CI:
0.96, 2.37, p = 0.07). The intervention was associated with increases in staff support of treat-
ment goals (100% vs. 95%, p = 0.01) and life goals (66% vs. 50%, p<0.01), the perceived
likelihood of other patients’ adherence (54% vs. 32%, p<0.01), support from other patients
(71% vs. 60%, p = 0.03), and being very satisfied with care (53% vs. 35%, p<0.01).
Conclusions
This novel intervention has the potential to improve the clinic experience, short-term reten-
tion in care, and ART adherence. Future studies are needed to expand the generalizability
of the approach and evaluate effectiveness on clinical outcomes.
Trial registration
Clinicaltrials.gov NCT02938533
Introduction
Most antiretroviral therapy (ART) regimens require more than 80–95% adherence to maxi-
mize the probability of viral suppression,[1–4] the ultimate goal of treatment that has signifi-
cant clinical benefits and can virtually eliminate HIV transmission.[5, 6] However, in sub-
Saharan Africa nearly 25% of people living with HIV infection (PLHIV) on treatment have
sub-optimal adherence and overall, only 29% of PLHIV are virally suppressed.[7, 8] Further-
more, disengagement from care is a pervasive threat to the effectiveness of ‘treatment as pre-
vention’ (TasP) strategies,[5] as only 65% of PLHIV in Africa are retained in care 36 months
after treatment initiation.[9] Thus, the common goal of governments and donors to reduce
HIV incidence and extend the lives of PLHIV necessitates creative, effective, and scalable strat-
egies to retain PLHIV in care and bolster ART adherence.[10]
Traditional strategies to improve ART treatment adherence, and health in general, often
erroneously assume that information is sufficient to change behavior. Such interventions pri-
marily rely on individuals’ innate desire to remain healthy; however, they ignore that decisions
are influenced by emotions, contexts, and systems as well as decision-making shortcuts that
are often outside of conscious awareness.[11] In contrast, there is growing interest in interven-
tions incorporating constructs from behavioral economics and psychology to account for our
predicable irrationalities, heuristics, and biases–thereby changing behavior without relying
solely on intrinsic or extrinsic motivation.[11–15] These strategies encompass approaches
such as incentives, defaults, and commitments, and they have been increasingly utilized to pro-
mote weight loss, smoking cessation, and the adoption of other beneficial health behaviors.[11,
15] However, there have been few applications to HIV/AIDS programs with the exception of
cash and in-kind incentives.[16, 17]
Using tools from marketing research and patient-centered design,[18] we developed and
implemented an intervention to improve ART adherence based on the concepts of norms and
priming. Social norms and social influence are increasingly recognized as powerful behavior
change tools.[11, 19] For example, a recent study reduced inappropriate antibiotic prescribing
by informing frequent prescribers that they were prescribing at a higher rate than 80% of other
practices.[20] After the intervention, there was a 3.3% reduction in antibiotic prescribing, trans-
lating to 73,406 fewer prescriptions during the short 6-month study period.[20] Programs tar-
geting social norms by engaging opinion leaders have also been evaluated for HIV prevention.
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[21] The intervention also used priming, which is when a stimulus, including sights, smells, and
sounds, subconsciously or indirectly influences another behavior.[11, 22, 23] Priming occurs
when simple associational cues activate aspects of one’s memory that then become more influ-
ential in processing new stimuli. For example, a fresh scent emitted at a medical center
increased hand washing before patient exams from 51% to 80%.[24] However, despite a prolif-
eration of studies using social norms and priming to change health and social behavior,[11, 19]
these principles have never, to our knowledge, been used to improve the health of PLHIV.
We hypothesized that a low-cost intervention based on social norms and priming that was
developed through an iterative, empathy-based design process could enhance TasP strategies
by increasing clinic attendance and ART adherence. The objective of the pilot study was there-
fore to evaluate the feasibility, acceptability, and short-term effectiveness of the intervention
on adherence and retention in care among adults attending two HIV clinics in Tanzania.
Methods
Study population
We conducted a quasi-experimental 6-month pilot study at two adult HIV care clinics in Shi-
nyanga, a resource-constrained region in Tanzania where HIV prevalence is 7.4%.[25] “Clinic
A” is a peri-urban government-run health center and “Clinic B” is a rural religiously-affiliated
dispensary; approximately 1,200–1,500 PLHIV were receiving care at each clinic in the last
quarter of 2015. The evaluation strategy included anonymous patient satisfaction surveys to
determine intervention acceptability and feasibility and a quantitative pilot study to examine
preliminary effects on retention in care and ART adherence after 6 months. Eligible partici-
pants were: 1) at least 18 years of age; 2) living with HIV infection; 3) and receiving HIV pri-
mary care at one of the two study clinics.
Intervention development
The intervention development process used patient-centered design (“design-thinking”)
and has been previously described.[26] Patient-centered design uses a creative, empathetic
approach that draws on ethnographic methods and relies on rapid prototyping and user test-
ing.[18] In brief, we used four approaches from design thinking: watching, listening, mapping,
and testing. This process included disciplined clinic (n = 6) and household observations
(n = 6), in-depth semi-structured (n = 19) and photo-based interviews (n = 5), a nominal
group approach to brainstorming to avoid group-think,[27] and focus groups (n = 4) for feed-
back on iterative intervention designs. We identified five ‘patient segments,’ an idea derived
from the concept of customer segments to guide business and marketing innovation, which
describe a group’s perception of health, risk factors for poor adherence, and potential interven-
tions. We created corresponding “journey maps” for each segment to represent stages in the
treatment experience that influence adherence and potential areas for intervention.[26, 28]
We designed the intervention using insights derived from the formative research (Table 1).
For example, we found that patients recognize one another at the clinic, offer support and
advice, and typically ignore written materials (e.g., posters) encouraging adherence. We
learned that fear of stigma causes some patients to go to great lengths to hide their treatment,
such as placing ART in empty lotion or soap bottles. We observed sparse households with few
non-essential objects except for outdated calendars, often used for decoration. In addition, we
found that patients’ lives have no connection to the clinic between appointments. A monthly
appointment is an anomaly, one day where everything revolves around living with HIV.
For many this is a particular challenge as there is a high financial opportunity cost for taking a
full day to visit the clinic and for some, a risk of disclosure. We determined that the ideal
Social norms and priming to improve adherence to antiretroviral therapy and retention in care
PLOS ONE | https://doi.org/10.1371/journal.pone.0177394 May 9, 2017 3 / 15
intervention would include a clinic component to leverage social norms and build social sup-
port, and a useful, inexpensive take-home component to increase engagement with health and
the clinic between visits, and a recognizable, self-relevant prime that appeared on all interven-
tion components.[29]
Intervention description
The final intervention included one clinic-based component to be implemented in both clinics
and two take-home components. All components included the priming image of a Baobab
tree (the “tree of life”), a positive image known by residents in Shinyanga where the trees are
numerous. It is immediately recognizable, associated with health and medicinal properties, and
regarded as a symbol of life and positivity in a landscape where little else can thrive. This image
was paired with the saying “Together we can hug the Baobab tree”, a play on a widely known
Tanzanian idiom about working together to achieve a goal. The saying was intended to convey
the support available to patients in the clinic from each other, the staff, and the community.
The clinic-based component was an interactive poster that rewarded appointment atten-
dance. Patients who attended three consecutive on-time visits were congratulated and given a
colored sticker to place on a poster that was publicly displayed at the clinic. We developed four
culturally relevant images, which we tested in focus groups, on which patients placed their
Table 1. Insights relevant to intervention development derived from the formative research phase,
using tools from marketing research and patient-centered design.
Key Insights for Intervention Development
1. Disclosure and stigma remain significant obstacles to antiretroviral therapy (ART) adherence and
retention in care in Shinyanga, Tanzania.
• People living with HIV infection will travel long distances to visit a clinic far from their community to avoid
recognition.
• Patients go to great lengths to hide ART during transport to and from the clinic. Although pills are
distributed in bottles, many patients immediately disguise them.
• Some patients ask strangers to pose as family members so that they can complete the first session of
adherence counseling (which requires the presence of a treatment supporter) and subsequently initiate
ART.
2. Existing clinical programs and materials do not connect with patients’ personal motivations and
beliefs for staying healthy.
• The impact of living with HIV and taking ART on patients’ social goals are inadequately addressed by
providers (e.g., having children, getting married).
• Patients do not look at materials in the clinic and typically cannot recall the content in these materials. In
contrast, patients associate health and wellbeing with images from daily life including performing farm work
(i.e., fetching water, harvesting crops) and sending children to school. Above all, people value images of
strength and community—these images may motivate health behaviors.
• Patients value traditional beliefs and approaches to maintaining health.
• People have few belongings in their homes except for useful objects, and no patients retain materials
from the clinic. Patients will keep some objects, such as calendars, after they are no longer useful if they
value the look and feel of the item.
3. Most of the time, patients living with HIV infection are disconnected from the clinic and
relationships with providers and other patients.
• Patients lack frequent touch points with the clinic and reminders to follow health recommendations.
• The clinic is an informal source of social support as patients often encounter the same patients on their
monthly visits. However, patients rarely interact with their peers outside of the clinic environment.
4. Patients value a positive clinic environment, but clinics have few reliable norms in practice.
• Patients value staff relationships and will travel out of their way to visit a clinic that has trustworthy and/
or highly competent staff.
• The behavior of staff is highly variable—some will congratulate patients, others scold. It is difficult to
predict a visit experience.
• Patients assume that many of their peers living with HIV are non-adherent.
https://doi.org/10.1371/journal.pone.0177394.t001
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sticker to collaboratively complete the picture; the accumulation of stickers conveyed that
regular clinic attendance is normative. For example, one poster was in the shape of a Baobab
tree and the stickers were the “leaves”. The prime image and motto was also on the poster.
The stickers had Kiswahili words from which the patient could select, such as “brave” and
“courageous”. In this activity, we expected the patient to feel positive emotions about his/her
accomplishment and to experience pride at others seeing him/her place the sticker, while
maintaining anonymity.
We developed two take-home components, one for each clinic. In Clinic A the take-home
component was a 2015 calendar in Kiswahili that contained the priming Baobab image and
idiom. The calendar contained six images, inspired by the photography exercise, that were
confirmed in focus groups to be associated with health, strength, and well-being, such as carry-
ing water, children in school uniforms, farming, and infants. The calendar had the potential
secondary benefit of helping people keep track of their appointments. In Clinic B the take-
home component was a small plastic pillbox featuring the Baobab logo and idiom. We hypoth-
esized that a simple pillbox (<$0.50) may alleviate some of the stress associated with inadver-
tent HIV disclosure, therefore improving adherence. We selected a 4-compartment case (1 3/
8" x 2 3/4" x 5/8") that could hold several ART doses (depending on regimen). The pill case
could fit in a pocket and was intentionally shaped like a feature phone, another measure to pre-
vent inadvertent disclosure of HIV status.
Sampling and data collection
We collected data from two samples of adult patients. First, patient satisfaction was measured
with an anonymous survey at baseline and endline (6 months). At both time points, the
research team approached a convenience sample of patients at the adult (18 years) HIV clinic
who were asked to complete a brief in-person interview about their clinic experience (baseline
and endline) and perceptions of the intervention (endline only).
Second, we conducted a quasi-experimental, 6-month pilot study at the two HIV treatment
clinics. Because the intervention was delivered at the clinic level, we could not randomly assign
individuals to the intervention. Instead, we assigned groups of individuals to the intervention
by implementing the intervention during two weeks of each month, with the other two weeks
per month as the comparison (standard of care) weeks. Because most PLHIV on ART in Tan-
zania follow strict 30- or 60-day visit schedules, this design assured that most (but not all) par-
ticipants were exposed to only the intervention or the standard of care when they returned to
the clinic for their regularly scheduled visits. The intervention began August 10th, 2015 and
was implemented every two weeks for 6 months.
This was a pilot study to primarily determine intervention acceptability and feasibility,
therefore we did not conduct formal sample size calculations. We determined that it was feasi-
ble to compare outcomes among approximately 400 patients, with the assumption that data
would be available for approximately 80% of patients. Patients were sampled using systematic
random sampling with a random start and a sampling interval in order to yield a final sample
that oversampled exposed patients. The final number sampled in each group depended on the
number of patients in each sampling frame at each clinic. We first used intervention logs that
we maintained to sample 393 patients who were exposed to the intervention in the first two
intervention periods, representing a mix of patients who received both a sticker and a take-
home component at baseline (100% of this “fully exposed” group was sampled, n = 193) and
those patients receiving only a take-home component at baseline (100 sampled per clinic) to
ensure adequate representation in the sample. In the analysis, we combined these groups
because patients who were partially exposed at baseline (by virtue of only receiving a take-
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home component) often moved into the “fully exposed” group during the intervention period,
so a single, combined intervention group was deemed most appropriate. We then used the
pharmacy dispensing register to select a sample of 149 unexposed patients who attended a
clinic visit in the first standard of care period. For all sampled patients with available records,
we abstracted visit attendance and pharmacy dispensing data from medical registers for the six
months following the sampled visit and the two appointments before the intervention period.
Outcomes
Intervention feasibility and acceptability was determined by questions directed to patients
about staff support for treatment and life goals, overall satisfaction with care received at the
clinic, and their experience with intervention components. The primary outcomes in the pilot
study were retention in care 6 months after baseline, defined as a visit between 150 and 210
days after the baseline visit (6 months +/- 30 days), and95% adherence to ART, measured
with the medication possession ratio (MPR). MPR is the proportion of days in an interval that
an individual was in possession of1 dose of ART, according to pharmacy dispensing data
and is highly correlated with viral suppression.[30] When patients transferred or died, we
truncated the 0–6 month interval to the last visit date. Otherwise the denominator of MPR
included all days in the 0–6 month interval. Secondary outcomes were “appointment adher-
ence,” the proportion of scheduled visits that were completed during the 6-month observation
period,[31] and MPR on a continuous scale.
Data analysis
We first describe responses to questions on the anonymous patient satisfaction survey and
compare baseline and endline values with Pearson’s chi-square test. We then examined
whether there were baseline differences between the intervention and comparison groups in
the pilot study by applying weights to account for the stratified sampling strategy and using t-
tests to compare means (i.e., MPR, appointment attendance) or survey design-corrected Pear-
son’s chi-square test to compare proportions.[32] We constructed unadjusted logistic (i.e.,
MPR95%, in care at 6 months) and linear (i.e., MPR, appointment attendance) regression
models to determine the association between intervention exposure, as defined by week of
clinic attendance at baseline, and the primary and secondary outcomes and report odds ratios
(ORs) and mean differences, respectively, with 95% confidence intervals (CIs). We repeated
this analysis after adjusting for clinic, which was imbalanced between study groups. These
analyses excluded 104 of 542 sampled patients: patients <18 years (n = 24), patients not yet on
ART (n = 6), patients without medical records (n = 73), and patients (n = 1) who transferred
before the first scheduled visit. The proportion of excluded patients did not differ by study
group (21% comparison vs. 20% intervention, p = 0.66). All analyses were weighted to account
for the sampling strategy and conducted with STATA v.14 (College Station, Texas).
We also conducted a sensitivity analysis to explore the effect of variable appointment sched-
uling and unscheduled visits on exposure to the intervention and its effectiveness. Specifically,
we found that during the 6 month intervention period, 71% and 21% of individuals in the
intervention and comparison groups, respectively, were exposed to the intervention during at
least half of their attended visits. To account for this imperfect treatment exposure and the
potential for confounding factors affecting both outcomes and actual treatment exposure, we
used an instrumental variable (IV) approach to estimate the intervention’s effectiveness on the
primary outcomes.[33] In these 2-stage least squares regression models, treatment assignment
(as determined by baseline visit week) was an instrument for the actual treatment exposure,
defined as50% of attended visits occurring during intervention periods.
Social norms and priming to improve adherence to antiretroviral therapy and retention in care
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Protection of human subjects
The Tanzanian National Institute of Medical Research and the Committee for Protection
of Human Subjects at the University of California, Berkeley approved this study. Written
informed consent was obtained from participants in in-depth interviews and focus group dis-
cussions conducted as part of the formative research. Verbal informed consent was obtained
from participants completing patient satisfaction surveys. Because the intervention was deliv-
ered at the clinic level to all patients, was intended to be a subtle cue and display of informa-
tion, involved minimal to no risk, and could be evaluated using de-identified existing data,
both ethical review boards determined that informed consent of participants in the pilot study
would be impractical and therefore granted a waiver of informed consent. The quasi-experi-
mental pilot study was registered in Clinicaltrials.gov (NCT02938533, https://clinicaltrials.gov/
show/NCT02938533) after retrospective data collection of existing data was complete in order
to conform with the International Committee of Medical Journal Editors policy. The authors
confirm that all ongoing and related trials for this intervention are registered.
Results
Intervention monitoring and implementation
During the six-month intervention period (August 10th–January 22, 2016), we implemented
three interactive posters at each clinic, each displaying a different image which participants
“filled” with stickers. We distributed 500 calendars (Clinic A) and 500 pillboxes (Clinic B) dur-
ing the first two intervention periods to clinic patients.
Intervention acceptability and feasibility
Overall, 405 patients completed the anonymous patient satisfaction survey (189 at baseline and
216 at endline). The median age was 40 years, 61% were female, and 51% attended clinic A;
there were no significant differences between participant characteristics at baseline and end-
line. Compared to baseline (Table 2), at endline we found significant increases in staff support
of treatment goals (100% vs. 95%) and life goals (66% vs. 50%), the perceived likelihood of
other patients’ high levels of adherence (54% vs. 32%), support from other patients (71% vs.
60%) and being very satisfied with clinical services and care (53% vs. 35%). There were signifi-
cant decreases in unanswered questions for providers (25% vs. 38%). At endline, patients who
reported ever viewing the poster more often reported that they would “definitely” take all of
their ART the following month (99%) compared to patients who had not viewed the poster
(93%, p = 0.03). Furthermore, the proportion of patients who were “very satisfied” with care
was non-significantly higher among patients who reported viewing the poster (56%) compared
to those who had not viewed the poster (44%, p = 0.11). Open-ended questions revealed that
patients found the interactive poster and process of earning a sticker acceptable, noting that it
made them feel “good for being recognized” as a “hero” or “champion.” Among pillbox recipi-
ents, all (100%) reported using the box to store treatment. Among those who received a calen-
dar, 85% reported using it to track appointments.
Retention in care and ART adherence
Medical records were reviewed for 438 randomly sampled patients, 320 exposed to the inter-
vention and 118 receiving standard of care, from January 27, 2016 to April 26, 2016 (Fig 1). At
baseline, age, sex, time on ART, regimen and appointment adherence were similar in the inter-
vention and comparison groups, whereas Clinic B was overrepresented in the treatment group
(62% vs. 55%, p<0.01, Table 3). During the study period, MPR95% was achieved by 64% of
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sampled patients, 83% of patients remained in care after 6 months, and mean appointment
attendance was 69%.
Table 2. Patient satisfaction at baseline and after the six-month intervention period (endline), Shinyanga, Tanzania, 2015–2016.
Characteristic Adult Patients at Baseline (n = 189) Adult Patients at Endline (n = 216) χ2 p-value
n (%) n (%)
Clinic Environment
Satisfaction with services and care
Less than satisfied 7 (3.7) 5 (2.3) 14.2 <0.01
Satisfied 116 (61.7) 96 (44.4)
Very satisfied 65 (34.6) 115 (53.2)
Enjoy being at the clinic
Disagree/Strongly disagree 35 (18.5) 29 (13.5) 1.9 0.17
Agree/Strongly agree 154 (81.5) 186 (86.5)
Other patients support me
Disagree/Strongly disagree 75 (39.7) 63 (29.2) 5 0.03
Agree/Strongly agree 114 (60.3) 153 (70.8)
Patient-Provider Interactions
Staff support treatment goals
Not supportive 9 (4.8) 0 (0) 10.7 <0.01
Supportive 99 (52.4) 123 (56.9)
Very supportive 81 (42.9) 93 (43.1)
Staff support life goals
Not supportive 95 (50.3) 73 (33.8) 12.8 <0.01
Supportive 81 (42.9) 114 (52.8)
Very supportive 13 (6.9) 29 (13.4)
Unanswered questions today
Yes 72 (38.1) 53 (24.5) 8.7 <0.01
No 117 (61.9) 163 (75.5)
Given instruction by pharmacist today
Yes 95 (50.3) 134 (62.0) 5.7 0.02
No 94 (49.7) 82 (38.0)
Understanding of instructions
Understood some/none 4 (4.2) 5 (3.8) 0.03 0.86
Understood all 91 (95.8) 128 (96.2)
Patient Adherence
Likelihood of attending scheduled
visit
Definitely 175 (92.6) 200 (92.6) 0 1
Not sure/Probably not 14 (7.4) 16 (7.4)
Likelihood of taking all ART this
month
Definitely 180 (95.2) 210 (97.2) 1.1 0.29
Not sure 9 (4.8) 6 (2.8)
Likelihood of others taking all ART
Most 60 (31.7) 116 (53.7) 25.8 <0.01
Some 36 (19.1) 36 (16.7)
Few 18 (9.5) 22 (10.2)
Not sure 75 (39.7) 42 (19.4)
https://doi.org/10.1371/journal.pone.0177394.t002
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In unadjusted and adjusted analyses, PLHIV exposed to the intervention were significantly
more likely to be in care after 6 months (87% vs. 79%, ORa = 1.73, 95% CI: 1.08, 2.78, p<0.05,
Table 4) and were more likely to achieve MPR95% (70% vs. 59%, ORa = 1.51, 95% CI: 0.96,
2.37, p = 0.07), although this result was not statistically significant after adjustment for clinic.
The intervention and comparison groups had similar average MPRs (90% vs. 89%, adjusted
mean difference = 0.0, 95% CI: -0.04, 0.04, p = 1.0) and appointment adherence (73% vs. 66%,
adjusted mean difference = 0.04, 95% CI: -0.01, 0.09, p = 0.09). When stratified by clinic, the
effects were concentrated at Clinic A, where we observed a 16 percentage point increase in
retention in care at 6 months (83% vs. 68%, OR = 2.38, 95% CI: 1.28, 4.44, p<0.01), a 24%
increase in retention. The sensitivity analysis using an IV analysis approach generated similar
results to the main analysis; results are presented as Supporting Information (S1 Table).
Discussion
We developed and conducted a pilot evaluation of a combined intervention inspired by the
concepts of social norms and priming to improve retention in care and adherence to ART
among people living with HIV infection in Tanzania. We found that the intervention was fea-
sible and acceptable to patients and was associated with temporal improvements in the per-
ceived level of support from staff and other patients as well as improvements in satisfaction
with clinic services. Results from the quasi-experimental pilot study indicate that the interven-
tion was associated with better retention in care and potentially a higher proportion of PLHIV
achieving MPR95% over a short 6-month follow-up period. These promising findings sug-
gest that the application of innovative, low-cost approaches from behavioral economics and
psychology, such as social norms and priming, may enhance the HIV care continuum and bol-
ster the effectiveness of ART programs, including TasP.
Fig 1. Study flowchart.
https://doi.org/10.1371/journal.pone.0177394.g001
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The combination intervention included components that were intended to leverage multi-
ple motivational pathways to influence a diverse group of PLHIV. First, the intervention lever-
aged social norms through an interactive poster intended to motivate PLHIV to attend clinic
appointments and pick up ART from the pharmacy. Several studies have demonstrated the
power of social influence,[11, 19] which is the idea that individuals use norms to compare and
adjust their own behavior.[34] The interactive poster’s creative visual feedback about norms
was deisgned to allow patients to benchmark their adherence behavior against others attending
the same clinic, and potentially incite better visit attendance and/or adherence. Although we
do not know the exact mechanism of action, after our intervention, patients were significantly
more likely to say that other patients would take most of their ART in the next month, a finding
that may be linked to the interactive poster which demonstrated that adherence to scheduled
Table 3. Characteristics of adult HIV primary care clinic patients, stratified by intervention exposure
at baseline, Tanzania, 2015–2016.
Characteristica Intervention Comparison Test statistice p-value
N = 320 N = 118
Age (%)
18–29 0.19 0.16 0.27 0.84
30–39 0.32 0.35
40–49 0.28 0.27
50 0.21 0.22
Sex (%)
Female 0.62 0.55 2.93 0.09
Male 0.38 0.45
Time on ART (%)
90 days 0.13 0.10 2.41 0.07
3–12 months 0.19 0.14
1–3 years 0.28 0.39
>3 years 0.40 0.37
ART initiate (%)b
Yes 0.13 0.10 0.98 0.32
No 0.87 0.90
Baseline Appointment Attendance (%)c 0.74 0.73 0.09 0.93
Regimen (%)d
3TC(150mg)/AZT(300mg)/NVP(200mg) 0.11 0.08 0.83 0.47
AZT(300mg)/3TC(150mg)/EFV(600mg) 0.12 0.12
TDF(300)/FTC(200)/EFV(600mg) 0.09 0.13
TDF(300)/3TC(300)/EFV(600mg) 0.68 0.67
Clinic (%)
Clinic A 0.38 0.45 12.29 0.001
Clinic B 0.62 0.55
a. Weighted statistics to account for sampling strategy. Missing data for weighted patient sample: 2% age,
2% sex, 3% time on ART, 1% baseline appointment attendance, and 3% regimen.
b. Started ART90 days before baseline.
c. Attendance at the last two scheduled appointments (+/- 4 days) prior to the baseline visit.
d. Regimen recorded at the baseline visit.
e. Survey design-corrected Pearson’s Chi-square test for categorical variables and t-test for continuous
variables.
https://doi.org/10.1371/journal.pone.0177394.t003
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appointments is normative. The poster may have also improved the overall clinic experience,
by recognizing the accomplishments of PLHIV, eliciting pride and social support when one
earned a sticker and physically placed it on the poster in view of fellow patients. In addition,
this investment in the social fabric of clinics may have created a motivating and positive clinic
environment. These hypotheses may warrant further investigation.
The intervention was also designed to include a prime that was identity-relevant, meaning
that the cue was related to one’s self-concept (e.g., gender, race, or group membership, such
as PLHIV) and therefore hypothesized to stimulate ‘identity congruent’ behavior.[35] For
example, people buy products or behave in a manner that is consistent with their self-image,
despite not being consciously aware of the stimuli’s influence. We hypothesize that the Baobab
logo and idiom about social support was relevant to patients’ identity as a person living with
HIV infection in Shinyanga, and reminded them that they have a support system, even if they
had not disclosed their HIV-infected status to friends and family. PLHIV in the study had
many opportunities for exposure to the prime: the image appeared on posters, pillboxes,
and calendars, and Baobab trees are ubiquitous in Shinyanga. This may have subconsciously
motivated PLHIV to attend visits and retrieve ART before their supply was exhausted. Only
13% of the patients surveyed could recall the Baobab logo, suggesting that the prime, if was
effective, operated primarily outside of conscious awareness as intended.[22] However, neither
our intervention nor experimental approach was singularly designed around assessing the
impact of the prime alone, and instead treats the image as one component of a combination
intervention.
Lastly, our empathetic approach to intervention design led to practical take home compo-
nents (calendars and pillboxes) that built upon people’s natural behavior and preferences and
subtly displayed the priming image. Formative research indicated that patients were already
Table 4. Crude and adjusted associations between intervention exposure and retention in HIV care and adherence to antiretroviral therapy after 6
months, Tanzania, 2015–2016.
Mean (95% CI) at 6 months a Estimated Associations
Intervention (N = 320) Comparison (N = 118) Unadjusted Site-Adjustedg
ORe (95% CI) ORa (95% CI)
Retained in careb 0.87 (0.85, 0.90) 0.79 (0.73, 0.86) 1.83 (1.16, 2.91)** 1.73 (1.08, 2.78)*
MPR95%c 0.70 (0.65, 0.74) 0.59 (0.50, 0.67) 1.62 (1.08, 2.41)* 1.51 (0.96, 2.37)
Mean Difff (95% CI) Mean Diffa (95% CI)
MPRc 0.90 (0.87, 0.92) 0.89 (0.86, 0.92) 0.01 (-0.03, 0.05) 0 (-0.04, 0.04)
Visit Attendanced 0.73 (0.70, 0.75) 0.66 (0.61, 0.71) 0.06 (0.01, 0.12)* 0.04 (-0.01, 0.09)
CI: confidence interval, OR = Odds ratio
*p0.05
**p0.01
a. Weighted analyses to account for sampling strategy.
b. Whether the patient was in care at 6 months, defined as a visit between 150 and 210 days (6 months +/- 30 days). Excluding <1% of weighted sample
who transferred before 6 months.
c. Medication possession ratio, the proportion of time an individual is in possession of1 ART dose. Excluding 21% of weighted sample who were missing
dispensing data for at least one recorded visit.
d. The proportion of scheduled appointments attended (+/- 4 days) during the 6-month intervention period. Excluding <1% of weighted sample who were
missing all scheduled visit records.
e. Based on logistic regression by treatment.
f. Based on linear regression by treatment.
g. Adjusted for clinic site.
https://doi.org/10.1371/journal.pone.0177394.t004
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hiding their pills; the pillbox intervention made this activity simpler. Similarly, patients already
displayed old calendars in their home; the new ones simply stimulated health behaviors in a
subtle way through images. Both calendars and pillboxes are considered “passive reminder
devices” that can improve adherence to ART.[36] Together, the low-cost intervention compo-
nents were intended to subtly motivate a heterogeneous group of PLHIV to remain engaged in
HIV care.
The intervention’s effects were strongest at a busy, government-run clinic (Clinic A) where
patients received a calendar as the take-home component. At this clinic, our formative re-
search revealed that patients travel very far and often couple their clinic visit with a visit to
large nearby market, which provides a useful (non-HIV related) explanation for being away
from home. Furthermore, we found that patient-provider interactions at Clinic A were often
negative–which suggested that a simple intervention to improve the clinic experience and
remind patients about attendance may work well. In contrast, at Clinic B where the effects
were weaker, patients benefitted from staff who were inherently more service oriented, even
introducing a new lunch program during the study whereby patients attending three consecu-
tive scheduled visits were provided with a coupon for a free lunch at a local establishment.
Although we were pleased that the clinic appreciated and duplicated the strategy to recognize
clinic attendance–perhaps a reflection of the inclusive design approach–this competing pro-
gram offered to all patients may have contaminated the standard of care group, thereby poten-
tially explaining the lack of a strong effect at Clinic B. Nevertheless, future studies are needed
to understand the influence of the clinical setting and participant characteristics on the success
of approaches using behavioral economics and/or psychology. It may also to be important to
understand the influence of the specific take-home component (i.e., pillbox, calendar) on these
results, which was beyond the scope or intention of this pilot study but could inform the design
of future interventions.
This study has several limitations. First, the intervention was designed and evaluated
among patients attending two clinics in Tanzania. Future studies will need to understand the
generalizability of the approach and rigorously measure its effectiveness on clinical outcomes.
In addition, given provider variability in scheduling appointments and unscheduled visits,
some patients in the intervention group attended clinic appointments during non-intervention
weeks, and vice versa. Although this resulted in some contamination of the comparison group,
results from our sensitivity analysis using an instrumental variable approach support our pri-
mary finding that the intervention improved retention in care and potentially ART adherence
(see S1 Table). Spillover effects are also possible, albeit unlikely, if intervention group clients
told peers about the intervention and that information changed the adherence behavior of
comparison group clients. Furthermore, we are unable to make statements about the effec-
tiveness of individual intervention components given that the intervention was designed as a
combination package. Future studies could consider whether individual components war-
rant independent evaluation. We did not measure viral suppression, the ultimate goal of
HIV treatment. However, MPR is closely correlated with short-term viral load.[30, 37] In
addition, as with many studies in resource-constrained settings, there is the potential for
poor data quality and missing data in paper-based facility registers; however, missing data
was not differential by study group. Furthermore, missing data would result in our study
underestimating ART adherence and retention in care. Lastly, patients self-reported satisfac-
tion and how they used the take-home components, which might be affected by social desir-
ability bias.
Our study also has significant strengths, including being the first of its kind to apply the
principles of social norms and priming to ART adherence and retention in care. We used tools
from marketing research and patient-centered design[18] to create an intervention that is
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responsive to the needs of PLHIV, and we evaluated its acceptability and potential effectiveness
in a quasi-experimental pilot study. The evaluation suggests that the intervention has the
potential to improve retention in care and adherence to ART over 6 months. These findings
are important not only for individual patients, due to the increased likelihood of HIV care and
viral suppression, but also for the health system due to increased value for money of the treat-
ment program. Governments and donors have invested millions of dollars into TasP pro-
grams; with a minimal budget, we increased retention and adherence, which could translate to
many more years of life given the scale of TasP programs. Future evaluation of this design and
intervention approach is warranted, especially in different geographic areas and with various
health outcomes.
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